Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

HIV

Items 11-20 of 30

Page
per page
  1. Dapivirine (TMC120)
    A8554 Dapivirine (TMC120)
    Target: Reverse Transcriptases
    Summary: Nonnucleoside reverse transcriptase inhibitor
      insoluble in H2O; ≥13.5 mg/mL
  2. Maraviroc
    A8311 Maraviroc
     2 Citation
    Target: CCR
    Summary: Selective CCR5 antagonist,antiretroviral agent
      ≥25.7 mg/mL
  3. Darunavir
    A8206 Darunavir
     2 Citation
    Summary: HIV-1 protease inhibitor
      ≥22.65 mg/mL
  4. Lopinavir
    A8204 Lopinavir
    Summary: HIV protease inhibitor,highly potent
      ≥31.45 mg/mL
  5. Ritonavir
    A8203 Ritonavir
    Summary: HIV protease inhibitor
      ≥26 mg/mL
  6. Amprenavir (agenerase)
    A8201 Amprenavir (agenerase)
    Summary: HIV-1 protease inhibitor
  7. S/GSK1349572
    A4074 S/GSK1349572
    Summary: HIV integrase inhibitor, novel and potent
      ≥41.9 mg/mL
  8. Raltegravir (MK-0518)
    A4073 Raltegravir (MK-0518)
     1 Citation
    Target: integrase
    Summary: HIV-1 integrase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.95 mg/mL
  9. Fluorouracil (Adrucil)
    A4071 Fluorouracil (Adrucil)
     12 Citation
    Target: Thymidylate Synthase
    Summary: Antitumor agent;inhibitor of thymidylate synthase
      insoluble in EtOH; ≥10.04 mg/mL
  10. Elvitegravir (GS-9137)
    A4070 Elvitegravir (GS-9137)
    Target: HIV Integrases
    Summary: HIV-1 integrase inhibitor,potent
      insoluble in H2O; insoluble in EtOH; ≥20.35 mg/mL

Items 11-20 of 30

Page
per page